Startup India Government of India
Samprit Formulations Private Limited
Samprit Formulations Private Limited - healthcare in Akola, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.72 Lakh
▼ 51% YoY
Net loss · FY 2024
₹94,400
Net margin -34.8%
EBITDA · FY 2024
-₹89,610
EBITDA margin -33%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Samprit Formulations Private Limited
Data last updated:
Samprit Formulations Private Limited is a private limited company based in Akola, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 05 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U33100MH2021PTC356414. Its GSTIN is 27ABFCS6153D1ZD (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Ajit A Kulkarni and Manoj Shriram Umbarkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Adarsh Sahakari Vasahat Nilin Appt. Flat No. 2, Akola, Maharashtra, India – 444001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.72 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹94,400 (net margin -34.8%) and EBITDA of -₹89,610 (EBITDA margin -33%).
Company details
CIN U33100MH2021PTC356414
Registration Number 356414
Incorporation Date 05 March 2021
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Samprit Formulations
Contact details
Samprit Formulations Private Limited's registered office is in Akola, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressAdarsh Sahakari Vasahat Nilin Appt. Flat No. 2, Akola, Maharashtra, India – 444001
- IndustryHealthcare, Manufacturing, Medical Appliances And Instruments
To see the full contact details of Samprit Formulations Private Limited, buy the company report.
Comprehensive company report
Samprit Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Samprit Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Samprit Formulations Private Limited, buy the company report.
Financials of Samprit Formulations Private Limited
FY 2025 filings availableSamprit Formulations Private Limited reported revenue of ₹2.72 Lakh (down 51% YoY) for FY 2024.
Revenue · FY 2024
₹2.72 Lakh ▼ 51%
Net loss · FY 2024
₹94,400 margin -34.8%
EBITDA · FY 2024
-₹89,610 margin -33%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 51%
EBITDA CAGR growth
1 year
▼ 881%
Revenue fell 51% in the latest year. EBITDA fell 881% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹89,610 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹94,400 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -33% | |||
| Net Profit Margin | -34.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Samprit Formulations Private Limited, buy the company report.
Board of directors of Samprit Formulations Private Limited
Samprit Formulations has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit A Kulkarni | Director | 05 Mar 2021 | 5 Years 7 Months | Current |
| Manoj Shriram Umbarkar | Director | 05 Mar 2021 | 5 Years 7 Months | Current |
| Parshant Ramrao Lambe | Director | 05 Mar 2021 | 5 Years 7 Months | Current |
| Madhuri Rajganesh Bodhankar | Additional Director | 14 Apr 2021 | 5 Years 6 Months | Current |
| Shriram Prabhakarrao Patil | Director | 05 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Samprit Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Samprit Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Samprit Formulations Private Limited has 1 active EPFO establishment as of Mar 23, 2024.
Active EPFO establishments
1
GST
Samprit Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABFCS6153D1ZD | Maharashtra | Active | 24 May 2021 |
To see the full GST registrations and return filing status of Samprit Formulations Private Limited, buy the company report.
Recent activity
Samprit Formulations Private Limited has 5 board changes on record since 2021: 5 appointments. The latest: Madhuri Rajganesh Bodhankar was appointed as Additional Director on 14 Apr 2021.
AGM
Samprit Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Samprit Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Appointed
Madhuri Rajganesh Bodhankar was appointed as Additional Director.
Appointed
Ajit A Kulkarni was appointed as Director.
Appointed
Manoj Shriram Umbarkar was appointed as Director.
Appointed
Parshant Ramrao Lambe was appointed as Director.
Appointed
Shriram Prabhakarrao Patil was appointed as Director.
Incorporation
05 Mar 2021
Samprit Formulations Private Limited was registered on 05 Mar 2021 with Roc Nagpur & aged 5 years 7 months as per MCA records.
Frequently asked questions
Samprit Formulations is an active private limited company based in Akola, Maharashtra, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 05 March 2021 (5+ years old) and is registered under CIN U33100MH2021PTC356414.
Samprit Formulations has 5 current directors:
- Ajit A Kulkarni - Director
- Manoj Shriram Umbarkar - Director
- Parshant Ramrao Lambe - Director
- Madhuri Rajganesh Bodhankar - Additional Director
- Shriram Prabhakarrao Patil - Director
The latest financial statements of Samprit Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Samprit Formulations is 27ABFCS6153D1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Samprit Formulations is U33100MH2021PTC356414. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samprit Formulations was incorporated on 05 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Nagpur.
Madhuri Rajganesh Bodhankar was appointed as Additional Director on 14 Apr 2021. Ajit A Kulkarni was appointed as Director on 05 Mar 2021. Manoj Shriram Umbarkar was appointed as Director on 05 Mar 2021. Samprit Formulations has 5 board changes on record in total.
Yes, Samprit Formulations is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Samprit Formulations is at Adarsh Sahakari Vasahat Nilin Appt. Flat No. 2, Akola, Maharashtra, India – 444001.
Samprit Formulations operates in the healthcare industry, in the manufacturing segment.